🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cancer-related cognitive Impairment (CRCI), commonly referred to as "chemo ...
Status
Terminated
Location
Hôpital Hôtel-Dieu de Lévis
Start Date
2017-10-09
Trial ID
NCT02970500
Treatments Being Tested
Primary Objective: * To assess the efficacy of immediate release methylphe...
Status
Terminated
Location
U.T.M.D. Anderson Cancer Center
Start Date
2004-02
Trial ID
NCT00418691
Treatments Being Tested
The purpose of this study is to show that Prepulse inhibition test of acous...
Status
Unknown
Location
The mental health clinic for children and adolescents at the HaEmek Medical Center
Start Date
2015-01
Trial ID
NCT02344784
Treatments Being Tested
This study looks to examine whether or not INTUNIV extended release can hel...
Status
Completed
Location
JPM van Stralen Medicine Professional Corporation
Start Date
2013-10
Trial ID
NCT01985581
Treatments Being Tested
Attention deficit/hyperactivity disorder (ADHD) is a common neurological di...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05635318
1. To examine whether Ritalin has analgesic properties in healthy subjects....
Status
Completed
Location
Rambam Healthcare Campus
Start Date
2013-07
Trial ID
NCT01914822
Treatments Being Tested
This is a study of blood plasma levels of methylphenidate in healthy volunt...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01118702
Treatments Being Tested
The study hypothesis is that some children with Attention-Deficit-Hyperacti...
Status
Unknown
Location
Assaf Haroffeh Medical Center
Start Date
2011-06
Trial ID
NCT01393574
Treatments Being Tested
Attention Deficit/Hyperactivity Disorder (ADHD) is one the most prevalent m...
Status
Terminated
Location
Sheba medical center
Start Date
2017-02-01
Trial ID
NCT02063945
Treatments Being Tested